DeepMed Research

Vall d'Hebron Research Institute

🇪🇸Spain

Country: 🇪🇸Spain

Ownership: Private

Established: 1994-01-01

Employees: 1K

Market Cap: -

Website: http://www.vhir.org

Clinical Trials

Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease.

Phase 3

Recruiting

Conditions: Portal Hypertension
Hepatocellular Carcinoma
Advanced Chronic Liver Disease

Interventions: Drug: Zinc Acexamate

First Posted Date: 2024-05-30

Last Posted Date: 2024-06-04

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 300

Registration Number: NCT06434753

Locations: 🇪🇸
Hospital Universitari Vall d'Hebron, Barcelona, Spain

Study of the Drivers of Late Diagnosis of Alcohol Related Diseases, Alone or in Combination With Metabolic Dysfunconal Associated Fatty Liver Disease, Implementation and Evaluation of Itnerventions to Reduce Its Burden.

Not Applicable

Recruiting

Conditions: Metabolic Disfunction Associated Steatotic Liver Disease
Alcohol-related Liver Disease
Alcohol Use Disorder
Metabolic and Alcohol Related/Associated Liver Disease

Interventions: Behavioral: brief intervention

First Posted Date: 2024-05-07

Last Posted Date: 2024-05-07

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 350

Registration Number: NCT06403332

Locations: 🇪🇸
Hospital Universitari Vall d'Hebron, Barcelona, Spain
🇪🇸
University Hospital Vall d'Hebron, Barcelona, Spain

The Preoperative Administration of ICG Improves Tumor Detection in Patients Undergoing Minimally Invasive Hepatic Resection Guided by Conventional Intraoperative Ultrasound.

Phase 4

Recruiting

Conditions: Liver Tumor; Surgery

First Posted Date: 2024-05-03

Last Posted Date: 2024-05-03

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 173

Registration Number: NCT06398028

Locations: 🇪🇸
Hospital Universitari Vall d'Hebron, Barcelona, Spain

Visible Abdominal Distension

Not Applicable

Not yet recruiting

Conditions: Dyspepsia
Irritable Bowel Syndrome
Functional Bloating

Interventions: Behavioral: Placebo
Behavioral: Biofeedback

First Posted Date: 2024-04-17

Last Posted Date: 2025-05-14

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 100

Registration Number: NCT06369753

Locations: 🇺🇸
G. Oppenheimer Center for Neurobiology of Stress and Resilience, Los Angeles, California, United States
🇨🇦
McMaster University, Hamilton, Ontario, Canada
🇫🇷
Bordeaux University Hospital, Bordeaux, France

and more 4 locations

Enteral Supplementation With Docosahexaenoic Acid and Arachidonic Acid (DHA-AA) in Preterm Infants

Not Applicable

Recruiting

Conditions: Infant, Premature, Diseases

Interventions: Dietary Supplement: DHA/AA emulsion supplement for preterm infant

First Posted Date: 2024-04-16

Last Posted Date: 2024-04-19

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 80

Registration Number: NCT06366893

Locations: 🇪🇸
Hospital Materno Infantil Vall d'Hebron, Barcelona, Spain

Development of Self-administrable Psychological Intervention Programs Supported by New Technologies as a Treatment for Patients With Functional Digestive Disorders.

Not Applicable

Recruiting

Conditions: Irritable Bowel Syndrome

Interventions: Behavioral: Placebo
Behavioral: Psychological intervention

First Posted Date: 2024-03-19

Last Posted Date: 2024-03-19

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 100

Registration Number: NCT06318572

Locations: 🇪🇸
Hospital Universitari Vall d'Hebron, Barcelona, Spain

Effectiveness of a Psychoeducational Intervention on Myositis Patients' Quality of Life and Well-Being

Not Applicable

Completed

Conditions: Quality of Life
Myositis

Interventions: Behavioral: Placebo
Behavioral: Psychoeducative

First Posted Date: 2024-03-08

Last Posted Date: 2024-03-08

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 34

Registration Number: NCT06300983

Locations: 🇪🇸
Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona, Barcelona, Spain

Diamine Oxidase and Adverse Pregnancy Outcomes

Recruiting

Conditions: Pregnancy Complications

First Posted Date: 2024-02-28

Last Posted Date: 2024-03-20

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 75

Registration Number: NCT06281366

Locations: 🇪🇸
Manel Mendoza, Barcelona, Spain

Treatment of Fecal Incontinence and Functional Defecation Disorders Using Non-instrumental Biofeedback

Not Applicable

Recruiting

Conditions: Outlet Dysfunction Constipation
Fecal Incontinence

Interventions: Behavioral: Placebo
Behavioral: Biofeedback

First Posted Date: 2024-02-22

Last Posted Date: 2024-04-25

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 96

Registration Number: NCT06273046

Locations: 🇪🇸
Hospital Vall d'Hebron, Barcelona, Spain

Impact of the Ex-vivo Pulmonary Perfusion System on the Microbiome of Lung Grafts and Their Inflammatory Reaction.

Not Applicable

Recruiting

Conditions: Lung Transplant Failure

Interventions: Device: Cold preservation
Device: EVLP

First Posted Date: 2024-02-09

Last Posted Date: 2024-02-09

Lead Sponsor: Vall d'Hebron Institute Research

Target Recruit Count: 7

Registration Number: NCT06250517

Locations: 🇪🇸
Hospital Clínic de Barcelona, Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy